|
|
||||||||
Unité de Glycobiologie Structurale et Fonctionnelle, UMR USTL/CNRS 8576 IFR147, Université des Sciences et Technologies de Lille, 59655 Villeneuve d'Ascq, Cedex, France
Correspondence
Jean-Marie Lacroix
Jean-Marie.Lacroix{at}univ-lille1.fr
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
Four genes are known to participate in OPG biosynthesis: two are needed for formation of the backbone (opgGH; Lacroix et al., 1991
) and two are needed for its substitution by phosphoglycerol (opgB; Jackson et al., 1984
; Lanfroy & Bohin, 1993
) and succinyl residues (opgC; Lacroix et al., 1999
). Phosphatidylethanolamine, exogenously added to intact cells, was shown to be a source of phosphoethanolamine residues that are transferred to OPGs (Miller & Kennedy, 1987
), but this activity was not further characterized because attempts to develop an in vitro assay were unsuccessful, and its gene remained unidentified. Actually, only two enzyme activities have been accurately defined in vitro, both of them being involved in the phosphoglycerol substitution of OPGs.
The first described phosphoglycerol transferase was a soluble protein found in the periplasmic space (Goldberg et al., 1981
). This enzyme was partially purified and has an apparent molecular mass of 56 000 in gel permeation chromatography. In vitro, it catalyses the transfer of phosphoglycerol to unsubstituted OPG molecules or model β-glucosides in the presence of Mn2+. However, the enzyme is unable to use phosphatidylglycerol as the donor substrate, but it catalyses the interchange of phosphoglycerol residues between OPG molecules. Moreover, at low concentration of acceptor, the enzyme acts as a cyclase with the liberation of cyclic phosphoglycerol.
The second described activity was a membrane-bound phosphoglycerol transferase. In vitro, the enzyme catalyses the transfer of phosphoglycerol residues from phosphatidylglycerol to OPGs or to synthetic β-glucoside acceptors such as arbutin (Jackson & Kennedy, 1983
). In vivo, the transfer occurs also to arbutin, which is not transported or degraded by the bacterium. Thus, this enzyme should have its catalytic site present on the periplasmic side of the cytoplasmic membrane (Bohin & Kennedy, 1984
).
Jackson & Kennedy (1983)
proposed a two-step model in which phosphoglycerol residues would be first transferred by the membrane-bound phosphoglycerol transferase I to newly synthesized glucans, still linked to the membrane. Then, the periplasmic phosphoglycerol transferase II would transfer those residues from one molecule of OPG (potentially still an acceptor in the first step) to another already liberated in the periplasmic space.
Mutants in the phosphoglycerol transfer (Jackson et al., 1984
) were isolated on the basis of the toxic accumulation of diacylglycerol resulting from addition of arbutin to the growth medium of a diacylglycerol kinase mutant (dgk). As expected from the model, the OPGs synthesized by these opgB mutants were devoid of phosphoglycerol. Moreover, crude extracts from an opgB strain still possessed the ability to remove phosphoglycerol residues from wild-type OPGs.
The opgB gene was cloned and localized immediately adjacent to the dnaTC operon (Lanfroy & Bohin, 1993
). Further characterization of the opgB gene product was hindered by an unusual instability of the protein, most of which was recovered in a soluble form. Thus, we decided to re-examine the relationship between the two enzymes.
| METHODS |
|---|
|
|
|---|
|
Recombinant DNA techniques.
Standard procedures (Sambrook et al., 1989
) were used for
DNA isolation, large-scale plasmid isolation and rapid analysis of recombinant plasmids. Restriction endonucleases (Biolabs), large (Klenow) fragment of DNA polymerase I, S1 nuclease and ligase of phage T4 (Gibco-BRL) were used according to the manufacturer's recommendations. Exonuclease III was used according to the method of Debarbieux et al. (1997)
.
DNA sequencing.
Double-stranded opgB–blaM fusion plasmid DNAs were sequenced according to the Sequenase version 2.0 sequencing protocol (United States Biochemicals). The sequencing primer hybridizing at the 5' end of blaM (5'-CCCACTCGTGCACCCAACT-3') was produced by Eurogentec.
Plasmid construction.
The opgB gene was cloned as follows.
phage 8D1 DNA (Kohara et al., 1987
) was first digested by SalI and KpnI (Fig. 1
) and the 3.6 kb DNA fragment containing the opgB gene was cloned into pBGS18 digested by SalI and KpnI to give pNF601. Then, the 2.6 kb HindIII DNA fragment of pNF601 was cloned into the HindIII site of pYZ4 (Debarbieux et al., 1997
) to give pNF604. For the construction of random fusion plasmids, the 3.2 kb SphI DNA fragment of pNF601 was cloned into the SphI site of pNF150 (Loubens et al., 1993
), thus placing the opgB gene upstream of a truncated version of blaM (pNF673). The resulting plasmid, pNF673, was digested by SstI and SalI before digestion by exonuclease III, allowing deletions of the opgB gene only. Two additional opgB–blaM fusions were generated as follows by direct cloning into restriction sites. For pNF710, plasmid pNF601 was digested by KpnI and DraI and the 1.2 kb DNA fragment was cloned into pNF150 digested by KpnI and EcoRV. For pNF717, plasmid pNF601 was digested by EcoRI and BamHI, blunt-ended by the large fragment of DNA polymerase I, and the 2.7 kb DNA fragment was cloned into pNF150 digested by XbaI and blunt-ended by the large fragment of DNA polymerase I. For the expression of a truncated version of OpgB deleted of its two first transmembrane segments, pNF604 was digested by BamHI and blunt-ended by S1 nuclease, thus deleting a 340 bp DNA fragment to give pNF721. Plasmid pNF596, in which opgB is fused to blaM after the codon for residue 164, was similarly engineered to give pNF723.
|
Assay of OPG substitution with [2-3H]glycerol.
The glycerol auxotrophic strain BB2636 and its opgB derivative (NFB758) were grown in LOS medium (5 ml) complemented with 1.35 mM [2-3H]glycerol (296 MBq mmol–1) and OPGs were extracted from overnight cultures as described previously (Lacroix et al., 1989
).
Determination of neutral and anionic characteristics of OPGs.
Cultures (5 ml) of DF214 were grown in LOS medium; 0.24 mM D-[U-14C]glucose (125 MBq mmol–1) was added in the exponential growth phase for various times and the reaction was stopped by adding 1 ml 30 % TCA. OPGs were then extracted and purified as described above and desalted on a PD10 column (Pharmacia Biotech) equilibrated with Tris/HCl 10 mM (pH 7.4). Fractions containing OPGs were pooled and chromatographed on a DEAE-Sephacel column (1.5 cmx38 cm, Pharmacia Biotech) equilibrated with Tris/HCl 10 mM (pH 7.4) and eluted with the same buffer containing increasing concentrations of NaCl ranging from 0 M to 1 M by steps of 0.05 M. A volume of 60 ml was used for each NaCl concentration and the volume of each collected fraction was 4 ml. When necessary, fractions of one peak were pooled and the succinyl substituents of OPGs were removed by incubation in 100 mM KOH for 2 h at 30 °C. Treated OPGs were then desalted and chromatographed on a DEAE-Sephacel column as previously described.
Determination of ampicillin resistance of cells expressing β-lactamase fusion proteins.
The ampicillin resistance of individual cells of NFB732 containing opgB–blaM fusion plasmids was determined according to Debarbieux et al. (1997)
.
Cellular location of fusion proteins.
Soluble or membrane-bound location of fusion proteins was determined according to Loubens et al. (1993)
.
Partial purification of periplasmic proteins.
Cells of strain 678 and derivatives were grown in LB without NaCl (100 ml). When cell densities reached 6x108 cells ml–1, periplasmic protein release was performed according to Loubens et al. (1993)
. One hundred microlitres of BSA (50 mg ml–1) was added to the periplasmic protein-containing supernatant as a tracer. This supernatant was chromatographed on Sephadex G-50 (1 cmx18 cm) at 4 °C. Protein content of each fraction of 1 ml was measured as A260. Fractions containing proteins (7 ml) were pooled, partially purified and concentrated in Macrosep 30K tubes (Pall Filtron) at 3000 g for 5 h at 4 °C to a final volume of 350 µl.
Cyclic phosphoglycerol assay.
The method was adapted from Goldberg et al. (1981)
, in which the activity of the enzyme was measured by cleavage and formation of cyclic phosphoglycerol from OPGs. The incubation buffer contained 50 mM Tris/HCl (pH 7.8), 0.25 mM MnCl2, 2.5 mg BSA ml–1 and 3.5 µM [2-3H]glycerol-labelled OPGs (285 000 d.p.m. nmol–1). The final volume of reaction was 200 µl. After addition of periplasmic proteins (145 µl), samples were incubated at 37 °C for various times. The reactions were stopped by the addition of 1 ml charcoal suspension (Norit A, 20 mg ml–1 in distilled water). Samples were then vigorously agitated for 10 min. Unlike OPGs, cyclic phosphoglycerol is not adsorbed on charcoal. Thus, the charcoal-containing labelled OPGs was removed by centrifugation at 8000 g for 10 min. Radioactivity of the supernatant, containing [2-3H]glycerol-labelled cyclic phosphoglycerol liberated by the enzyme, was counted. Activity was calculated according to Goldberg et al. (1981)
.
| RESULTS AND DISCUSSION |
|---|
|
|
|---|
Amino acid sequence analysis of OpgB and prediction of its topology
OpgB is a protein with a deduced molecular mass of 85 494 Da. This is in agreement with the apparent molecular mass of 84 000 Da calculated from SDS-PAGE during the analysis of gene products located at the vicinity of the dnaTCyjjA operon (Masai & Arai, 1988
). The deduced protein OpgB was found to be a member of the alkaline phosphatase superfamily of metalloenzymes (Galperin et al., 1998
) and its amino acids 163–448 form a conserved sulfatase domain (Pfam00884, http://pfam.jouy.inra.fr, Bateman et al., 2002
). The dense alignment surface (DAS) method (http://www.sbc.su.se/
miklos/DAS, Cserzo et al., 1997
) and the TopPred II algorithm (http://bioweb.pasteur.fr/seqanal/interfaces/toppred.html, Claros & von Heijne, 1994
) allowed the prediction of the same three or four membrane-spanning segments in the first 124 amino acids (Fig. 1
). We have no evidence for the existence of the putative transmembrane segment located in the vicinity of the N-terminal part of OpgB, which is not represented in Fig. 1
. Four consecutive arginine residues are found in a 9 amino acid sequence between the two last transmembrane segments. Taking into account the positive inside rule, one can deduce that the hydrophilic C-terminal part of the protein (amino acids 125–763) is responsible for its catalytic activity on the periplasmic face of the membrane (Bohin & Kennedy, 1984
). To test the validity of this model (Fig. 1
), β-lactamase was used as a topological reporter.
Analysis of opgB–blaM gene fusions
Twenty-three in-frame opgB–blaM fusions were obtained after exonuclease III digestion (see Methods). The position of the β-lactamase moiety (cytoplasmic or periplasmic) was determined for each fusion by streaking the colonies, up to individual cells, on LB agar plates containing 50 µg ampicillin ml–1. All the fusions conferred resistance on individual cells, indicating that these strains have a β-lactamase moiety in the periplasmic space. The fusion point between the opgB and truncated blaM genes of the 23 fusions was determined by DNA sequencing. Then, nine of them, regularly spaced over the OpgB protein, were further characterized. Protein fusion points were downstream of amino acids 164 (P164), 228 (P228), 307 (P307), 371 (P371), 446 (P446), 529 (P529), 574 (P574), 652 (P652) and 747 (P747) (i.e. after transmembrane segment 3, see Fig. 1
). This random procedure did not give a fusion in the first 163 amino acids. Two opgB–blaM fusions were then generated by direct cloning into restriction sites (see Methods) with fusion points downstream of amino acids 41 (P41) and 97 (P97) (i.e. at the end of the predicted transmembrane segments 1 and 2 respectively, see Fig. 1
). Ampicillin resistance conferred by these two fusions indicated that the β-lactamase moieties were periplasmic and cytoplasmic respectively (Fig. 1
). To confirm the location of each fusion protein, crude extracts were prepared from cells of strain NFB732 harbouring the corresponding plasmids and the β-lactamase activity was determined in the supernatant (soluble activity) and the pellet (insoluble membrane-bound activity) after centrifugation at 150 000 g for 2 h as described previously (Loubens et al., 1993
). As expected, most of the β-lactamase activity was recovered in the pellet for the two first fusion proteins (89 % and 83 % for P41 and P97 respectively). Surprisingly, most of the β-lactamase activity was recovered in the supernatant for the nine other fusion proteins (99 %, 78 %, 73 %, 78 %, 84 %, 84 %, 76 %, 69 % and 87 % for P164, P228, P307, P371, P446, P529, P574, P652 and P747 respectively). Thus, only P41 and P97 were found to be membrane-bound. These results confirmed the topological orientation of the three membrane-spanning segments. All the fusions beyond amino acid 163 were found to be essentially soluble. These results suggested a proteolytic cleavage of OpgB.
Phosphoglycerol transferase II is encoded by opgB
Phosphoglycerol transferase II was initially characterized from soluble proteins extracted from 600 g (wet weight) of E. coli cells after several purification steps (Goldberg et al., 1981
). When opgB mutants were obtained, their phosphoglycerol transferase II activities were determined by the phosphoglycerol cyclase test on total soluble proteins in crude extracts without subsequent purification steps. The activity was found to be similar in the mutant strains and in the wild-type strain (0.33 and 0.31 U mg–1 h–1 respectively), suggesting that two different genes encode the two phosphoglycerol transferases (Jackson et al., 1984
). In this work, we developed a micro-method using partially purified periplasmic extracts (see Methods). Three strains were compared for their phosphoglycerol cyclase activities (see Methods): strain 678, from which periplasmic extracts are particularly easy to obtain (Loubens et al., 1993
), an opgB derivative of strain 678 (NFB1814) and strain 678 harbouring plasmid pNF604 (opgB+). Accumulation of tritiated cyclic phosphoglycerol increased linearly for at least 2 h in assays performed with extracts from strain 678 and strain 678(pNF604). The level of cyclase activity was 0.25±0.01 U (mg protein)–1 h–1, 5.37±0.50 U (mg protein)–1 h–1 and 0.02±0.01 U (mg protein)–1 h–1 in periplasmic extracts from strain 678, strain 678(pNF604) and strain NFB1814 respectively. Whereas only a residual activity could be detected in NFB1814, a 25-fold increase in cyclase activity resulted from the introduction of the opgB+ plasmid in strain 678. Because of the difference between our data and those published by Jackson et al. (1984)
, crude extracts were also tested on our strains. Tritiated glycerol liberation activities were 0.70±0.01 U (mg protein)–1 h–1 and 0.30±0.01 U (mg protein)–1 h–1 for strain 678 and NFB1814 respectively. The apparent discrepancy between the data is most probably the result of a non-specific cytoplasmic activity present in crude extracts but absent from periplasmic extracts. Thus, the membrane-bound and the soluble phosphoglycerol transferase are encoded by the same gene.
Analysis of phosphoglycerol transferase II activity in vivo
From the model (Fig. 1
) it is obvious that the cleavage should occur before the conserved sulfatase domain, just downstream of the third transmembrane segment. A deletion of plasmid pNF604 allowed the fusion of the two first codons of lacZ (encoded by the vector) with the codon corresponding to the last residue of the second transmembrane segment of OpgB (pNF721). The SignalP program (Nielsen et al., 1997
, http://www.cbs.dtu.dk/services/SignalP/) allowed the prediction that signal peptidase I could recognize the remaining transmembrane segment as a signal sequence with a cleavage site between Ala124 and Ser125. A similar construction was done with OpgB fused to BlaM downstream of amino acid 164, and its ampicillin-resistance phenotype indicated that the hybrid protein was expressed as a soluble periplasmic protein.
Plasmid pNF721 was introduced into strain BB2636 (a glycerol auxotroph that enables a specific and quantitative labelling of OPGs with [2-3H]glycerol, Bohin & Kennedy, 1984
) and into its opgB derivative NFB758. OPGs were extracted from overnight cultures. In the presence of the plasmid, the OPG radioactivity remained null in the opgB background but was increased by 79 % in the wild-type background. These OPGs were further analysed by DEAE-Sephacel chromatography (Fig. 2
). As described previously, OPGs of E. coli can be separated by this method in five subfractions corresponding to increasing charge-to-mass ratios (Lacroix et al., 1999
, see Fig. 3
). In strain BB2636(pNF721), the glycerol content of subfractions IV and V was strongly increased (Fig. 2
). In conclusion, when the two first transmembrane segments of OpgB are deleted, a periplasmic protein is expressed that cannot complement a defect of phosphoglycerol transferase I activity but can increase significantly the phosphoglycerol substitution of OPGs in a wild-type background. These results demonstrate allotopic properties (Racker, 1967
) of OpgB, which can use phosphatidylglycerol as a donor substrate only when anchored in the cell membrane, in complete agreement with the two-step mechanism proposed by Jackson & Kennedy (1983)
.
|
|
Concluding remarks
The opgB gene encodes a protein which is anchored in the cytoplasmic membrane and has the properties of phosphoglycerol transferase I. After post-translational modification (probable cleavage between Ala124 and Ser125), this protein becomes a soluble, periplasmic protein whose enzymic activity changes into phosphoglycerol transferase II. The cgmB gene, encoding a phosphoglycerol transferase catalysing phosphoglycerol substitution of OPGs in Sinorhizobium meliloti, was characterized by Wang et al. (1999)
. Because CgmB of S. meliloti and OpgB of E. coli showed no significant similarity, and because CgmB is a soluble periplasmic protein, the authors suggested that CgmB may be more similar to phosphoglycerol transferase II. But, since in E. coli both phosphoglycerol transferase activities are encoded by the same gene, it appears that this hypothesis was not correct. In addition, no significant similarity was observed between Cgm and OpgC, two enzymes catalysing the succinyl substitution of OPGs in Brucella abortus (Roset et al., 2006
) and in E. coli (Lacroix et al., 1999
) respectively, or between these enzymes and both kinds of phosphoglycerol transferases. Thus, the various OPG substitution enzymes, which catalyse very similar reactions, have probably emerged from independent evolutions.
In E. coli, OPG synthesis occurs essentially at the inner-membrane level in a complex of proteins including four membrane proteins, two periplasmic proteins and one cytoplasmic protein (Bohin & Lacroix, 2006
). Succinyl substitution occurs very early in the synthetic process and probably during the glucose backbone synthesis itself. A primary substitution by phosphoglycerol residues occurs at the same time. However, supplementary substitution, facilitated by a soluble periplasmic enzyme, is needed to achieve complete anionic substitution of OPGs.
| ACKNOWLEDGEMENTS |
|---|
Edited by: J. Green
| REFERENCES |
|---|
|
|
|---|
Bell, R. M. (1974). Mutants of Escherichia coli defective in membrane phospholipid synthesis: macromolecular synthesis in an sn-glycerol-3-phosphate acyltransferase Km mutant. J Bacteriol 117, 1065–1076.
Bohin, J.-P. & Kennedy, E. P. (1984). Regulation of the synthesis of membrane-derived oligosaccharides in Escherichia coli. Assay of phosphoglycerol transferase I in vivo. J Biol Chem 259, 8388–8393.
Bohin, J.-P. & Lacroix, J.-M. (2006). Osmoregulation in the periplasm. In The Periplasm, pp. 325–341. Edited by M. Ehrmann. Washington, DC: American Society for Microbiology.
Claros, M. G. & von Heijne, G. (1994). TopPred II: an improved software for membrane protein structure predictions. Comput Appl Biosci 10, 685–686.
Cserzo, M., Wallin, E., Simon, I., von Heijne, G. & Elofsson, A. (1997). Prediction of transmembrane alpha-helices in prokaryotic membrane protein: the dense alignment surface method. Protein Eng 10, 673–676.
Debarbieux, L., Bohin, A. & Bohin, J.-P. (1997). Topological analysis of the membrane-bound glucosyltransferase, MdoH, required for osmoregulated periplasmic glucan synthesis in Escherichia coli. J Bacteriol 179, 6692–6698.
Galperin, M. Y., Bairoch, A. & Koonin, E. V. (1998). A superfamily of metalloenzymes unifies phosphopentomutase and cofactor-independent phosphoglycerate mutase with alkaline phosphatases and sulfatases. Protein Sci 7, 1829–1835.[Medline]
Goldberg, D. E., Rumley, M. K. & Kennedy, E. P. (1981). The biosynthesis of membrane-derived oligosaccharides: a periplasmic phosphoglycerol transferase. Proc Natl Acad Sci U S A 78, 5513–5517.
Jackson, B. J. & Kennedy, E. P. (1983). The biosynthesis of membrane-derived oligosaccharides: a membrane-bound phosphoglycerol transferase. J Biol Chem 258, 2394–2398.
Jackson, B. J., Bohin, J.-P. & Kennedy, E. P. (1984). Biosynthesis of membrane derived oligosaccharides: characterization of opgB mutants defective in phosphoglycerol transferase I activity. J Bacteriol 160, 976–981.
Kennedy, E. P. (1996). Membrane derived oligosaccharides (periplasmic beta-D-glucans) of Escherichia coli. In Escherichia coli and Salmonella: Cellular and Molecular Biology, 2nd edn, pp. 1064–1074. Edited by F. C. Neidhardt and others. Washington, DC: American Society for Microbiology.
Kohara, Y., Akiyama, K. & Isono, K. (1987). The physical map of the whole Escherichia coli chromosome: application of a new strategy for rapid analysis and sorting of a large genomic library. Cell 50, 495–508.[CrossRef][Medline]
Lacroix, J.-M., Tempête, M., Menichi, B. & Bohin, J.-P. (1989). Molecular cloning and expression of a locus (mdoA) implicated in the biosynthesis of the membrane-derived oligosaccharides in Escherichia coli. Mol Microbiol 3, 1173–1182.[CrossRef][Medline]
Lacroix, J.-M., Loubens, I., Tempête, M., Menichi, B. & Bohin, J.-P. (1991). The mdoA locus of Escherichia coli consists of an operon under osmotic control. Mol Microbiol 5, 1745–1753.[CrossRef][Medline]
Lacroix, J.-M., Lanfroy, E., Cogez, V., Lequette, Y., Bohin, A. & Bohin, J.-P. (1999). The mdoC gene of Escherichia coli encodes a membrane protein that is required for succinylation of osmoregulated periplasmic glucans. J Bacteriol 181, 3626–3631.
Lanfroy, E. & Bohin, J.-P. (1993). Physical map location of the Escherichia coli gene encoding phosphoglycerol transferase I. J Bacteriol 175, 5736–5737.
Loubens, I., Debarbieux, L., Bohin, A., Lacroix, J.-M. & Bohin, J.-P. (1993). Homology between a genetic locus (mdoA) involved in the osmoregulated biosynthesis of periplasmic glucans in Escherichia coli and a genetic locus (hrpM) controlling pathogenicity of Pseudomonas syringae. Mol Microbiol 10, 329–340.[CrossRef][Medline]
Masai, H. & Arai, K.-I. (1988). Operon structure of dnaT and dnaC genes essential for normal and stable DNA replication of Escherichia coli chromosome. J Biol Chem 263, 15083–15093.
Miller, J. H. (1992). A Short Course in Bacterial Genetics. A Laboratory Manual and Handbook for Escherichia coli and Related Bacteria. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
Miller, K. J. & Kennedy, E. P. (1987). Transfer of phosphoethanolamine residues from phosphatidylethanolamine to the membrane-derived oligosaccharides of Escherichia coli. J Bacteriol 169, 682–686.
Nielsen, H., Engelbrecht, J., Brunak, S. & von Heijne, G. (1997). Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites. Protein Eng 10, 1–6.
Racker, E. (1967). Resolution and reconstitution of the inner mitochondrial membrane. Fed Proc 26, 1335–1340.[Medline]
Roset, M. S., Ciocchini, A. E., Ugalde, R. A. & Inon de Iannino, N. (2006). The Brucella abortus cyclic beta-1,2-glucan virulence factor is substituted with O-ester-linked succinyl residues. J Bacteriol 188, 5003–5013.
Sambrook, J., Fritsch, E. F. & Maniatis, T. (1989). Molecular Cloning: a Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
Van Golde, L. M. G., Schulman, H. & Kennedy, E. P. (1973). Metabolism of membrane phospholipids and its relation to a novel class of oligosaccharides in Escherichia coli. Proc Natl Acad Sci U S A 70, 1368–1372.
Vieira, J. & Messing, J. (1982). The pUC plasmids, an M13 mp7-derived system for insertion mutagenesis and sequencing with synthetic universal primers. Gene 19, 259–268.[CrossRef][Medline]
Vinopal, R. T., Hillman, J. D., Schulman, H., Reznikoff, W. S. & Fraenkel, D. G. (1975). New phosphoglucose isomerase mutants of Escherichia coli. J Bacteriol 122, 1172–1174.
Wang, P., Ingram-Smith, C., Hadley, J. A. & Miller, K. J. (1999). Cloning, sequencing, and characterization of the cgmB gene of Sinorhizobium meliloti involved in cyclic beta-glucan biosynthesis. J Bacteriol 181, 4576–4583.
Received 11 September 2007;
revised 19 October 2007;
accepted 25 October 2007.
This article has been cited by other articles:
![]() |
D. Lu, M. E. Wormann, X. Zhang, O. Schneewind, A. Grundling, and P. S. Freemont Structure-based mechanism of lipoteichoic acid synthesis by Staphylococcus aureus LtaS PNAS, February 3, 2009; 106(5): 1584 - 1589. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |